BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15334060)

  • 1. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.
    Singh V; Miranda TB; Jiang W; Frankel A; Roemer ME; Robb VA; Gutmann DH; Herschman HR; Clarke S; Newsham IF
    Oncogene; 2004 Oct; 23(47):7761-71. PubMed ID: 15334060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor DAL-1/4.1B modulates protein arginine N-methyltransferase 5 activity in a substrate-specific manner.
    Jiang W; Roemer ME; Newsham IF
    Biochem Biophys Res Commun; 2005 Apr; 329(2):522-30. PubMed ID: 15737618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells.
    Jiang W; Newsham IF
    Mol Cancer; 2006 Jan; 5():4. PubMed ID: 16420693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.
    Yu T; Robb VA; Singh V; Gutmann DH; Newsham IF
    Biochem J; 2002 Aug; 365(Pt 3):783-9. PubMed ID: 11996670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3).
    Swiercz R; Person MD; Bedford MT
    Biochem J; 2005 Feb; 386(Pt 1):85-91. PubMed ID: 15473865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation.
    Tang J; Gary JD; Clarke S; Herschman HR
    J Biol Chem; 1998 Jul; 273(27):16935-45. PubMed ID: 9642256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast Hsl7 (histone synthetic lethal 7) catalyses the in vitro formation of omega-N(G)-monomethylarginine in calf thymus histone H2A.
    Miranda TB; Sayegh J; Frankel A; Katz JE; Miranda M; Clarke S
    Biochem J; 2006 May; 395(3):563-70. PubMed ID: 16426232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer.
    Yi C; McCarty JH; Troutman SA; Eckman MS; Bronson RT; Kissil JL
    Mol Cell Biol; 2005 Nov; 25(22):10052-9. PubMed ID: 16260618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing Sarcoma protein and a peptide.
    Pahlich S; Bschir K; Chiavi C; Belyanskaya L; Gehring H
    Proteins; 2005 Oct; 61(1):164-75. PubMed ID: 16044463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain.
    Frankel A; Clarke S
    J Biol Chem; 2000 Oct; 275(42):32974-82. PubMed ID: 10931850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT3 inhibits ubiquitination of ribosomal protein S2 and together forms an active enzyme complex.
    Choi S; Jung CR; Kim JY; Im DS
    Biochim Biophys Acta; 2008 Sep; 1780(9):1062-9. PubMed ID: 18573314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling substrates of protein arginine N-methyltransferase 3 with S-adenosyl-L-methionine analogues.
    Guo H; Wang R; Zheng W; Chen Y; Blum G; Deng H; Luo M
    ACS Chem Biol; 2014 Feb; 9(2):476-84. PubMed ID: 24320160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNase treatment of yeast and mammalian cell extracts affects in vitro substrate methylation by type I protein arginine N-methyltransferases.
    Frankel A; Clarke S
    Biochem Biophys Res Commun; 1999 Jun; 259(2):391-400. PubMed ID: 10362520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein N-arginine methylation in adenosine dialdehyde-treated lymphoblastoid cells.
    Li C; Ai LS; Lin CH; Hsieh M; Li YC; Li SY
    Arch Biochem Biophys; 1998 Mar; 351(1):53-9. PubMed ID: 9500843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT3 is essential for dendritic spine maturation in rat hippocampal neurons.
    Miyata S; Mori Y; Tohyama M
    Brain Res; 2010 Sep; 1352():11-20. PubMed ID: 20647003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas.
    Martinez-Glez V; Bello MJ; Franco-Hernandez C; De Campos JM; Isla A; Vaquero J; Rey JA
    Int J Mol Med; 2005 Oct; 16(4):771-4. PubMed ID: 16142420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.
    Pahlich S; Zakaryan RP; Gehring H
    Proteins; 2008 Sep; 72(4):1125-37. PubMed ID: 18320585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.